Abstract
EP300 gene encodes E1A-associated protein p300 that function as co-activators of transcription and regulates transcription via chromatin remodeling. Pathogenic variants in EP300 on chromosome 22q13.2 have been reported in about 5–10% of individuals with Rubinstein-Taybi syndrome (RTS2) [OMIM# 613684], as well as in few patients with Menke-Hennekam syndrome (MKHK2) [OMIM# 618333]. In addition, it may function as a potential oncogene as somatic variants in EP300 have been reported in various cancers with high prevalence such as skin squamous cell carcinoma, marginal zone B-cell lymphoma, bladder carcinoma, and follicular lymphoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
